Geneviève Ameye
Cliniques Universitaires Saint-Luc
17 Papers
46 Citations
Geneviève Ameye is an academic researcher from Cliniques Universitaires Saint-Luc. The author has contributed to research in topics: Fluorescence in situ hybridization & Biology. The author has an hindex of 10, co-authored 15 publications. Previous affiliations of Geneviève Ameye include University College London.
Chat about Author
Papers
Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders.
Fiona M Ross,Hervé Avet-Loiseau,Geneviève Ameye,Norma C. Gutiérrez,Peter Liebisch,Sheila J.M. O’Connor,Klara Dalva,Sonia Fabris,Adele M. Testi,Marie Jarošová,Clare Hodkinson,Anna Collin,Gitte Kerndrup,Petr Kuglík,D. Ladon,Paolo Bernasconi,Brigitte Maes,Zuzana Zemanova,Kyra Michalova,Lucienne Michau,Kai Neben,N. Emil U. Hermansen,Katrina Rack,Alberto Rocci,Rebecca K.M. Protheroe,Laura Chiecchio,Hélène Poirel,Pieter Sonneveld,Mette Nyegaard,Hans Erik Johnsen +29 more
TL;DR: The primary clinical applications for FISH analysis were for newly diagnosed cases of MM or frank relapse cases and prospective analysis should be centralized for upcoming trials based on the recommendations made.
308
Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping
Katrina Rack,Jolien De Bie,Geneviève Ameye,Olga Gielen,Sofie Demeyer,Jan Cools,Kim De Keersmaecker,Joris Vermeesch,Johan Maertens,Heidi Segers,Lucienne Michaux,Barbara Dewaele +11 more
TL;DR: Optical genome mapping increased the detection rate and cytogenetic resolution, and abrogated the need for cascade testing, resulting in reduced turnaround times, and provided opportunities for better patient stratification and accurate treatment options.
56
KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.
Sandrine Medves,François Duhoux,Augustin Ferrant,Federica Toffalini,Geneviève Ameye,Jeanne-Marie Libouton,Hélène Poirel,Jean-Baptiste Demoulin +7 more
TL;DR: KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia.
45
Genetic differences between paediatric and adult Burkitt lymphomas.
Violaine Havelange,Xavier Pepermans,Geneviève Ameye,Ivan Théate,Evelyne Callet-Bauchu,Carole Barin,Dominique Penther,Eric Lippert,Lucienne Michaux,Francine Mugneret,Nicole Dastugue,Martine Raphael,Miikka Vikkula,Hélène Poirel,Hélène Poirel +14 more
TL;DR: For the first time, different genetic anomalies between adult and paediatric BLs are reported, suggesting age‐related heterogeneity in Burkitt lymphomagenesis, which may explain the poorer prognosis of adult BLs.
31
The peculiar 11q-gain/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma.
Violaine Havelange,Geneviève Ameye,Ivan Théate,Evelyne Callet-Bauchu,Eric Lippert,Isabelle Luquet,Martine Raphael,Miikka Vikkula,Hélène Poirel +8 more
TL;DR: A new subset of MYC-negative, high grade B-cell lymphoma with features of BL was recently identified in immunocompetent patients and in post-transplant Immunocompromised patients, and is associated with an excellent survival rate, which is similar to typical BL.
26